Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALPHA INTERFERON AND CIS-RETINOIC ACID FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMAS

NCT00002506 is registered in ClinicalTrials.gov with Hoag Memorial Hospital Presbyterian as lead sponsor.

NCT NCT00002506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALPHA INTERFERON AND CIS-RETINOIC ACID FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMAS
Lead sponsor
Hoag Memorial Hospital Presbyterian
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1992
Completion date
February 28, 1999
Enrollment
Not reported
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, esophageal cancer, head and neck cancer, lung cancer, non-melanomatous skin cancer, penile cancer